PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification

Background. There is a patent need to better characterize early-stage colorectal cancer (CRC) patients. PD-1 ligand (PD-L1) expression has been proposed as a prognostic factor but yields mixed results in different settings. The Consensus Molecular Subtype (CMS) classification has yet to be integrate...

Full description

Bibliographic Details
Main Authors: Pablo Azcue, Ignacio Encío, David Guerrero Setas, Javier Suarez Alecha, Arkaitz Galbete, María Mercado, Ruth Vera, Maria Luisa Gomez-Dorronsoro
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
CMS
Online Access:https://www.mdpi.com/2072-6694/13/8/1943

Similar Items